Form 4 for AMPH Amphastar Pharmaceuticals, Inc.
Accepted 2023-03-08 00:00:00 ET · period of report 2023-03-06 · accession 0001104659-23-030133 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-08 | 2023-03-06 | AMPH | PETERS WILLIAM J | CFO, EVP, Treas | A - Grant | $0.00 | +23.9K | 124.5K | +24% | $0 |
| D | 2023-03-08 | 2023-03-06 | AMPH | PETERS WILLIAM J | CFO, EVP, Treas | A - Grant | $0.00 | +50.4K | 50.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-06 | A | A | 23,925 | $0.00 | 124,539 | D | — | — | (F1) The reported shares are represented by restricted stock units, or RSUs, which vest in four equal annual installments beginning on March 6, 2024. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2023-03-06 | A | A | 50,416 | $0.00 | 50,416 | D | $35.13 · — to 2033-03-06 | 50,416 Common Stock | (F2) The shares subject to the option vest in four equal annual installments beginning on March 6, 2024. |